PHENDIMETRAZINE TARTRATE
PHENDIMETRAZINE TARTRATE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: PHENDIMETRAZINE TARTRATE; Generic name: PHENDIMETRAZINE TARTRATE; Manufacturer: Bryant Ranch Prepack.
| Brand name | PHENDIMETRAZINE TARTRATE |
|---|---|
| Generic name | PHENDIMETRAZINE TARTRATE |
| Manufacturer | Bryant Ranch Prepack |
| Used for | INDICATIONS AND USAGE Phendimetrazine tartrate tablets are indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (see CLINICAL PHARMACOLOGY ) should be measured against possible risk factors inherent in their use such as those described below. |
| Dosage | DOSAGE AND ADMINISTRATION Usual Adult Dose: 1 tablet (35 mg) b.i.d. or t.i.d., one hour before meals. Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets t.i.d. |
| Warnings | WARNINGS Tolerance to the anorectic effect of phendimetrazine develops within a few weeks. When this occurs, its use should be discontinued; the maximum recommended dose should not be exceeded. Use of phendimetrazine tartrate within 14 days following the administration of monoamine oxidase inhibitors may result in a hypertensive crisis. Abrupt cessation of administration following prolonged high dosage results in extreme fatigue and depression. Because of the effect on the central nervous system |
| Active ingredient(s) | PHENDIMETRAZINE TARTRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=137e5fcd-9536-4fb9-9885-5dfd1127c35a |